世界の肺炎球菌ワクチン市場予測 2021年-2026年

◆英語タイトル:Global Pneumococcal Vaccine Market Growth 2021-2026
◆商品コード:LPI21JL16735
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月
◆ページ数:134
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
LP Information社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

LPインフォメーション社の「肺炎球菌ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、PPSV23、 PCV7/13、 PCV10など、用途別には、子供用、大人用などにセグメント区分してまとめました。肺炎球菌ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・肺炎球菌ワクチンの世界市場概要(サマリー)
・肺炎球菌ワクチンの企業別販売量・売上
・肺炎球菌ワクチンの企業別市場シェア
・肺炎球菌ワクチンの世界市場規模 2016年-2021年:種類別(PPSV23、 PCV7/13、 PCV10)
・肺炎球菌ワクチンの世界市場規模 2016年-2021年:用途別(子供用、大人用)
・肺炎球菌ワクチンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・肺炎球菌ワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・肺炎球菌ワクチンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・肺炎球菌ワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・肺炎球菌ワクチン市場の成長要因・課題・動向
・肺炎球菌ワクチンの世界市場予測 2021年-2026年
・肺炎球菌ワクチンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・肺炎球菌ワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・肺炎球菌ワクチンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・肺炎球菌ワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・肺炎球菌ワクチンの世界市場予測:種類別(PPSV23、 PCV7/13、 PCV10)
・肺炎球菌ワクチンの世界市場予測:用途別(子供用、大人用)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Pneumococcal Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6966.9 million in 2020. Over the next five years the Pneumococcal Vaccine market will register a 1.1% CAGR in terms of revenue, the global market size will reach US$ 7290.4 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
PPSV 23
PCV 7/13
PCV 10

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Child
Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccine Consumption 2016-2026
2.1.2 Pneumococcal Vaccine Consumption CAGR by Region
2.2 Pneumococcal Vaccine Segment by Type
2.2.1 PPSV 23
2.2.2 PCV 7/13
2.2.3 PCV 10
2.3 Pneumococcal Vaccine Sales by Type
2.3.1 Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2016-2021)
2.4 Pneumococcal Vaccine Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccine Sales by Application
2.5.1 Global Pneumococcal Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Pneumococcal Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pneumococcal Vaccine Sale Price by Application (2016-2021)

3 Global Pneumococcal Vaccine by Company
3.1 Global Pneumococcal Vaccine Sales Market Share by Company
3.1.1 Global Pneumococcal Vaccine Sales by Company (2019-2021)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Pneumococcal Vaccine Revenue Market Share by Company
3.2.1 Global Pneumococcal Vaccine Revenue by Company (2019-2021)
3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Pneumococcal Vaccine Sale Price by Company
3.4 Global Manufacturers Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Vaccine Product Location Distribution
3.4.2 Players Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pneumococcal Vaccine by Region
4.1 Global Pneumococcal Vaccine by Region
4.1.1 Global Pneumococcal Vaccine Sales by Region
4.1.2 Global Pneumococcal Vaccine Revenue by Region
4.2 Americas Pneumococcal Vaccine Sales Growth
4.3 APAC Pneumococcal Vaccine Sales Growth
4.4 Europe Pneumococcal Vaccine Sales Growth
4.5 Middle East & Africa Pneumococcal Vaccine Sales Growth

5 Americas
5.1 Americas Pneumococcal Vaccine Sales by Country
5.1.1 Americas Pneumococcal Vaccine Sales by Country (2016-2021)
5.1.2 Americas Pneumococcal Vaccine Revenue by Country (2016-2021)
5.2 Americas Pneumococcal Vaccine Sales by Type
5.3 Americas Pneumococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Pneumococcal Vaccine Sales by Region
6.1.1 APAC Pneumococcal Vaccine Sales by Region (2016-2021)
6.1.2 APAC Pneumococcal Vaccine Revenue by Region (2016-2021)
6.2 APAC Pneumococcal Vaccine Sales by Type
6.3 APAC Pneumococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Pneumococcal Vaccine by Country
7.1.1 Europe Pneumococcal Vaccine Sales by Country (2016-2021)
7.1.2 Europe Pneumococcal Vaccine Revenue by Country (2016-2021)
7.2 Europe Pneumococcal Vaccine Sales by Type
7.3 Europe Pneumococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa Pneumococcal Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pneumococcal Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa Pneumococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pneumococcal Vaccine Distributors
10.3 Pneumococcal Vaccine Customer

11 Global Pneumococcal Vaccine Market Forecast
11.1 Global Pneumococcal Vaccine Forecast by Region
11.1.1 Global Pneumococcal Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Pneumococcal Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pneumococcal Vaccine Forecast by Type
11.7 Global Pneumococcal Vaccine Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer Pneumococcal Vaccine Product Offered
12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Pneumococcal Vaccine Product Offered
12.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 MSD
12.3.1 MSD Company Information
12.3.2 MSD Pneumococcal Vaccine Product Offered
12.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 MSD Main Business Overview
12.3.5 MSD Latest Developments
12.4 Sanofipasteur
12.4.1 Sanofipasteur Company Information
12.4.2 Sanofipasteur Pneumococcal Vaccine Product Offered
12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sanofipasteur Main Business Overview
12.4.5 Sanofipasteur Latest Developments
12.5 CDIBP
12.5.1 CDIBP Company Information
12.5.2 CDIBP Pneumococcal Vaccine Product Offered
12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 CDIBP Main Business Overview
12.5.5 CDIBP Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Pneumococcal Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of PPSV 23
Table 3. Major Players of PCV 7/13
Table 4. Major Players of PCV 10
Table 5. Global Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 6. Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 7. Global Pneumococcal Vaccine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Pneumococcal Vaccine Sale Price by Type (2016-2021)
Table 10. Global Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 11. Global Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 12. Global Pneumococcal Vaccine Value by Application (2016-2021)
Table 13. Global Pneumococcal Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Pneumococcal Vaccine Sale Price by Application (2016-2021)
Table 15. Global Pneumococcal Vaccine Sales by Company (2019-2021) & (K Doses)
Table 16. Global Pneumococcal Vaccine Sales Market Share by Company (2019-2021)
Table 17. Global Pneumococcal Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2021)
Table 19. Global Pneumococcal Vaccine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pneumococcal Vaccine Products Offered
Table 22. Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pneumococcal Vaccine Sales by Region (2016-2021) (K Doses)
Table 26. Global Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 27. Global Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 29. Americas Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)
Table 30. Americas Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 31. Americas Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 33. Americas Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 34. Americas Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 35. Americas Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 36. Americas Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 37. APAC Pneumococcal Vaccine Sales by Region (2016-2021) & (K Doses)
Table 38. APAC Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 39. APAC Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 41. APAC Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 42. APAC Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 43. APAC Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 44. APAC Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 45. Europe Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)
Table 46. Europe Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 47. Europe Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 49. Europe Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 50. Europe Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 51. Europe Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 52. Europe Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)
Table 54. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 58. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 60. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Pneumococcal Vaccine
Table 62. Key Application and Potential Industries of Pneumococcal Vaccine
Table 63. Key Challenges of Pneumococcal Vaccine
Table 64. Key Trends of Pneumococcal Vaccine
Table 65. Pneumococcal Vaccine Distributors List
Table 66. Pneumococcal Vaccine Customer List
Table 67. Global Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Doses)
Table 68. Global Pneumococcal Vaccine Consumption Market Forecast by Region
Table 69. Global Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses)
Table 72. Americas Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Doses)
Table 74. APAC Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses)
Table 76. Europe Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses)
Table 78. Middle East & Africa Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Pneumococcal Vaccine Sales Forecast by Type (2021-2026) & (K Doses)
Table 80. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Pneumococcal Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Pneumococcal Vaccine Sales Forecast by Application (2021-2026) & (K Doses)
Table 84. Global Pneumococcal Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Pneumococcal Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Pneumococcal Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 87. Pfizer Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Pneumococcal Vaccine Product Offered
Table 89. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. GSK Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Pneumococcal Vaccine Product Offered
Table 94. GSK Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. MSD Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. MSD Pneumococcal Vaccine Product Offered
Table 99. MSD Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 100. MSD Main Business
Table 101. MSD Latest Developments
Table 102. Sanofipasteur Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofipasteur Pneumococcal Vaccine Product Offered
Table 104. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 105. Sanofipasteur Main Business
Table 106. Sanofipasteur Latest Developments
Table 107. CDIBP Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. CDIBP Pneumococcal Vaccine Product Offered
Table 109. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 110. CDIBP Main Business
Table 111. CDIBP Latest Developments
List of Figures
Figure 1. Picture of Pneumococcal Vaccine
Figure 2. Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Vaccine Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Pneumococcal Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pneumococcal Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of PPSV 23
Figure 10. Product Picture of PCV 7/13
Figure 11. Product Picture of PCV 10
Figure 12. Global Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 13. Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
Figure 14. Pneumococcal Vaccine Consumed in Child
Figure 15. Global Pneumococcal Vaccine Market: Child (2016-2021) & (K Doses)
Figure 16. Pneumococcal Vaccine Consumed in Adult
Figure 17. Global Pneumococcal Vaccine Market: Adult (2016-2021) & (K Doses)
Figure 18. Global Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Figure 19. Global Pneumococcal Vaccine Revenue Market Share by Application in 2020
Figure 20. Pneumococcal Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Pneumococcal Vaccine Revenue Market Share by Company in 2020
Figure 22. Global Pneumococcal Vaccine Sales Market Share by Regions (2016-2021)
Figure 23. Global Pneumococcal Vaccine Revenue Market Share by Region in 2020
Figure 24. Americas Pneumococcal Vaccine Sales 2016-2021 (K Doses)
Figure 25. Americas Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 26. APAC Pneumococcal Vaccine Sales 2016-2021 (K Doses)
Figure 27. APAC Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 28. Europe Pneumococcal Vaccine Sales 2016-2021 (K Doses)
Figure 29. Europe Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Pneumococcal Vaccine Sales 2016-2021 (K Doses)
Figure 31. Middle East & Africa Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. Americas Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 33. Americas Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 34. Americas Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 35. Americas Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 36. United States Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Pneumococcal Vaccine Sales Market Share by Region in 2020
Figure 41. APAC Pneumococcal Vaccine Revenue Market Share by Regions in 2020
Figure 42. APAC Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 43. APAC Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 44. China Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 51. Europe Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 52. Europe Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 53. Europe Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 54. Germany Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 63. Egypt Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の肺炎球菌ワクチン市場予測 2021年-2026年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆